Education
About Us
Working with TipRanks
Follow Us
4basebio UK Societas (GB:4BB)
LSE:4BB
RESEARCH TOOLSreports
Total Valuation
4basebio UK Societas has a market cap or net worth of £174.06M. The enterprise value is 208.50M.
Market Cap£174.06M
Enterprise Value208.50M
Share Statistics
4basebio UK Societas has 15,496,393 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding15,496,393
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
4basebio UK Societas’s return on equity (ROE) is 15.58 and return on invested capital (ROIC) is -73.61%.
Return on Equity (ROE)15.58
Return on Assets (ROA)-0.64
Return on Invested Capital (ROIC)-73.61%
Return on Capital Employed (ROCE)-0.83
Revenue Per Employee5.01K
Profits Per Employee-75.89K
Employee Count101
Asset Turnover0.04
Inventory Turnover0.50
Valuation Ratios
The current PE Ratio of 4basebio UK Societas is -10.93. 4basebio UK Societas’s PEG ratio is -0.23.
PE Ratio-10.93
PS Ratio0.00
PB Ratio-170.27
Price to Fair Value-170.27
Price to FCF-10.92
Price to Operating Cash Flow-13.56
PEG Ratio-0.23
Income Statement
In the last 12 months, 4basebio UK Societas had revenue of 506.00K and earned -7.67M in profits. Earnings per share was -0.62.
Revenue506.00K
Gross Profit340.00K
Operating Income-8.05M
Pretax Income-8.35M
Net Income-7.67M
EBITDA-7.34M
Earnings Per Share (EPS)-0.62
Cash Flow
In the last 12 months, operating cash flow was -9.93M and capital expenditures -885.50K, giving a free cash flow of -10.81M billion.
Operating Cash Flow-9.93M
Free Cash Flow-10.81M
Free Cash Flow per Share-0.70
Dividends & Yields
4basebio UK Societas pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.07
52-Week Price Change4.17%
50-Day Moving Average1.13K
200-Day Moving Average1.27K
Relative Strength Index (RSI)43.90
Average Volume (3m)1.19K
Important Dates
4basebio UK Societas upcoming earnings date is May 7, 2025, TBA Not Confirmed.
Last Earnings DateSep 27, 2024
Next Earnings DateMay 7, 2025
Ex-Dividend Date―
Financial Position
4basebio UK Societas as a current ratio of 2.21, with Debt / Equity ratio of -296.93%
Current Ratio2.21
Quick Ratio2.06
Debt to Market Cap0.11
Net Debt to EBITDA-1.01
Interest Coverage Ratio-26.66
Taxes
In the past 12 months, 4basebio UK Societas has paid -689.00K in taxes.
Income Tax-689.00K
Effective Tax Rate0.08
Enterprise Valuation
4basebio UK Societas EV to EBITDA ratio is -12.41, with an EV/FCF ratio of -11.89.
EV to Sales180.16
EV to EBITDA-12.41
EV to Free Cash Flow-11.89
EV to Operating Cash Flow-14.76
Balance Sheet
4basebio UK Societas has £2.72M in cash and marketable securities with £6.87M in debt, giving a net cash position of £12.78M billion.
Cash & Marketable Securities£2.72M
Total Debt£6.87M
Net Cash£12.78M
Net Cash Per Share£0.82
Tangible Book Value Per Share-£0.26
Margins
Gross margin is 69.63%, with operating margin of -1591.30%, and net profit margin of -1514.82%.
Gross Margin69.63%
Operating Margin-1591.30%
Pretax Margin-1650.99%
Net Profit Margin-1514.82%
EBITDA Margin-1451.19%
EBIT Margin-1591.30%
Analyst Forecast
The average price target for 4basebio UK Societas is £1,600.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target£1,600.00
Price Target Upside42.22% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―